Information for researchers

17th DSANJ Bio Conference 2025

Call for Submissions by Researchers

The Drug Seeds Alliance Network Japan (DSANJ) invites researchers from universities, research institutions, and startups to submit drug discovery research outcomes and platform technologies for DSANJ Bio Conference 2025. Those selected for the meetings by pharma companies and venture capital(VC) will get the opportunity to present their drug discovery seeds to them seeking partnering. DSANJ is a program aimed at matching state-of-the-art research with interested pharma companies and VC.

The DSANJ Admin Office arranges 40-minute one-on-one Zoom meetings between research entities and pharma companies and VC to explore the possibility of partnering.

Due to the limitations of the online format, approx. 70 meeting slots are available. Accordingly, slots will be allotted in order of the research entities that receive the most meetings requests from participating pharma companies and VC.

Applications to participate in DSANJ Bio Conference 2025 is accepted until November 6, 2025.

This is an invaluable opportunity to meet and forge partnerships with pharma companies and VC (we predict around 40 companies will participate). If you are looking to accelerate your research progress and its deployment in practical applications, we invite you to submit your entry for consideration in the DSANJ Bio Conference 2025.

DSANJ Bio Conference 2025: Overview

Purpose Promoting joint research, technology transfer and investment in drug discovery
Schedule Early 2026: 10:00–18:00 (JST) on Jan. 28, 29, 30; Feb. 2, 3
Location Meetings will be held online via Zoom—participate from wherever is convenient for you: your lab, conference room, home, etc.
  • NB: You will be able to access (test) the Zoom session prior to the meeting date to ensure you are able to access from your location.
Participants Approx. 80 researchers from universities, research institutions, startups, etc.
Approx. 40 pharma companies and VC
Fee Participation is free of charge, including in the event of a successful collaboration.
Organizers OCCI, Japan Agency for Medical Research and Development (AMED), Japan Pharmaceutical Manufacturers Association (JPMA), Kansai Pharmaceutical Industries Association
Co-organizer Osaka Prefecture
Support Japan External Trade Organization (JETRO), Osaka City
Special thanks Life Science Innovation Network Japan (LINK-J)

Click the links for more details.

Application Requirements

Notes of application
  1. Make sure that your proposal materials (Form 2) do not include confidential information. The DSANJ Bio Conference 2025 organizing and operations bodies will not treat as confidential any information received for the conference.
  2. Each researcher is limited to one proposal. If you would like to submit more than one proposal, please have another person (e.g., a co-researcher or someone else in your research group) present it.
  3. Special invitational slots are available for those who have received AMED research funding. Details will be provided by your liaison at AMED.
Application Deadline

Nov. 6, 2025 (JST)

  • If you are unlikely to be able to submit your application in time due to, for instance, coordination issues with co-researchers, contact the DSANJ Admin Office (as directed below) in advance and we will try to accommodate your application.
We welcome applications of ...
  • Research outcomes you would like to pursue further in partnership with pharma companies and VC
  • Outcomes of research supported by AMED
  • Outcomes of research led by JPMA
  • NB: We are eager to receive applications from startups and biotech companies.
Area of focus

  • Categories

    Drug targets; drug seeds (substances); platform technologies for drug discovery; biomarkers; diagnostic drugs and technologies; digital therapeutics; medical devices for use combination with drugs, etc. (i.e., excluding devices designed for use on their own)

  • Modalities

    Low-molecular drugs, antibody drugs, oligonucleotide therapeutics, gene therapy, recombinant protein, cell therapy, AI-powered drug discovery, vaccines, viruses, regenerative medicine, SaMD (treatment apps), digital healthcare, protein-protein interaction inhibitors, etc.

  • Target Disorders

    Metabolic disorders, circulatory disorders, infectious disorders, respiratory disorders, musculoskeletal disorders, cancer and malignant neoplasms, central nervous system disorders, pain, sensory organ disorders, immune system and inflammatory disorders, allergies, skin disorders, digestive and urinary disorders, ob-gyn disorders, rare disorders, etc.

  • Stage of Research Progress

    Basic research; non-clinical POC pending; non-clinical POC obtained, clinical trials pending; clinical trials underway, etc.
How to apply to participate To apply for DSANJ Bio Conference 2025, follow these steps.

  1. Step 1

    Download the required documents from the links in the required documentation section below.

    • You will also need to enter the information indicated below into the application webpage shown in Step 2. More detailed items for entry can be found there.

    Required information:
    Name (Japanese & English), organization (J&E), professional title (J&E), title of your proposal (J&E), keywords (J&E), profile information contained in your presentation (e.g., targeted disease, drug target, mechanism of action, modality, and whether or not your research includes platform technology relating to drug discovery)

  2. Step 2

    Save the things to check before participating (Form 1), your proposal materials (Form 2), and contact information (Form 3) to a single folder, save the folder as a Zip file, and submit the Zip file via this webpage:

    DSANJ Bio Conference 2025 Application Webpage

  3. Step 3

    The DSANJ Admin Office will send you an email with the “[Application Completed] DSANJ Registration Form”. If you do not receive an email from us, please contact us to check the status of your entry.
Required documentation

Click on the blue button to download the pertinent materials.

  • When filling out your application, make sure you fill out the forms for the 17th DSANJ Bio Conference 2025.

Things to check before participating (Form 1)

Things to check before participating

Your proposal materials (Form 2)

Proposal materials template (PPT: 111KB)

Contact information (Form 3)

Contact information (Excel: 14KB)

Read Before Preparing Proposal Materials

  • Preparing your proposal materials in accordance with the guidelines increases your chances of attracting pharma companies and VC attention.
  • For optimal uploading and downloading of images, keep your images within around 20MB. (We may resize your images if they are too large.)
    • Proposal Material Preparation Guidelines
    See below for examples of well-prepared proposal materials.
    • Sample proposal materials

Note that your materials will still be shared with participating pharmaceutical companies even if you are not selected to present at DSANJ Bio Conference 2025.
Notice of meeting schedules We will notify whether pharmaceutical companies have requested meetings with you around December 26, 2025. If you get meeting requests, we will also inform you of the number and schedules.

Contact

Name DSANJ Admin Office
(Life Science Group, Osaka Chamber of Commerce and Industry)
Contact Maki Inubushi, Mai Nakamura, Rui Uchimura, Ako Makiyama
Address 2-8 Honmachi-bashi, Chuo-ku, Osaka 541-0029 Japan
Contact Please contact us at the following e-mail address.
[E-mail Address: contact@dsanj.jp]
Phone +81-6-6944-6484 (09:00–17:00 JST)
  • Outside of those hours, please use the contact form.